Molecular and clinical characteristics of hepatitis B virus in Korea

SangHoon Ahn, Lilly Yuen, KwangHyub Han, Margaret Littlejohn, Hye Young Chang, Hans Damerow, Anna Ayres, Jeong Heo, Stephen Locarnini, Peter A. Revill

Research output: Contribution to journalArticle

28 Citations (Scopus)

Abstract

Korea is an endemic area of hepatitis B virus (HBV) infection but very little is known about the molecular characteristics of HBV isolates from Korean patients or the association with disease progression. The complete HBV genome sequences from 53 Korean patients with chronic hepatitis B, advanced cirrhosis, or hepatocellular carcinoma (HCC) were analyzed to identify (i) subgenotype distribution and genetic diversity and (ii) signature mutations associated with liver disease progression. With the exception of 1 patient infected with HBV/B, all 52 patients (98.1%) were infected with HBV/C, subgenotype C2. These strains were 98.4% identical and the frequency of amino acid substitutions occurring within key immunological epitopes increased with disease severity. A number of amino acid/ nucleotide substitutions were associated with HCC, namely sR24K (HBsAg), SI126T (HBsAg), and pcA1846T (precore gene) mutations (P=0.029, 0.001, and 0.008, respectively). HBV harboring deletions in the pre-S region were also associated with increased liver disease severity (chronic hepatitis B vs. cirrhosis, P=0.040; chronic hepatitis B vs. HCC, P=0.040). Despite the high degree of sequence conservation, several key HBV mutations were associated with disease progression. Prospective studies with larger cohorts of patients are required to evaluate further the clinical manifestation of HBV/C2 in Korea.

Original languageEnglish
Pages (from-to)1126-1134
Number of pages9
JournalJournal of Medical Virology
Volume82
Issue number7
DOIs
Publication statusPublished - 2010 Jan 1

Fingerprint

Korea
Hepatitis B virus
Chronic Hepatitis B
Disease Progression
Hepatocellular Carcinoma
Amino Acid Substitution
Hepatitis B Surface Antigens
Mutation
Liver Diseases
Fibrosis
Virus Diseases
Epitopes
Nucleotides
Genome
Prospective Studies
Genes

All Science Journal Classification (ASJC) codes

  • Virology
  • Infectious Diseases

Cite this

Ahn, S., Yuen, L., Han, K., Littlejohn, M., Chang, H. Y., Damerow, H., ... Revill, P. A. (2010). Molecular and clinical characteristics of hepatitis B virus in Korea. Journal of Medical Virology, 82(7), 1126-1134. https://doi.org/10.1002/jmv.21844
Ahn, SangHoon ; Yuen, Lilly ; Han, KwangHyub ; Littlejohn, Margaret ; Chang, Hye Young ; Damerow, Hans ; Ayres, Anna ; Heo, Jeong ; Locarnini, Stephen ; Revill, Peter A. / Molecular and clinical characteristics of hepatitis B virus in Korea. In: Journal of Medical Virology. 2010 ; Vol. 82, No. 7. pp. 1126-1134.
@article{2be3640678544d6b94b458be28542cbd,
title = "Molecular and clinical characteristics of hepatitis B virus in Korea",
abstract = "Korea is an endemic area of hepatitis B virus (HBV) infection but very little is known about the molecular characteristics of HBV isolates from Korean patients or the association with disease progression. The complete HBV genome sequences from 53 Korean patients with chronic hepatitis B, advanced cirrhosis, or hepatocellular carcinoma (HCC) were analyzed to identify (i) subgenotype distribution and genetic diversity and (ii) signature mutations associated with liver disease progression. With the exception of 1 patient infected with HBV/B, all 52 patients (98.1{\%}) were infected with HBV/C, subgenotype C2. These strains were 98.4{\%} identical and the frequency of amino acid substitutions occurring within key immunological epitopes increased with disease severity. A number of amino acid/ nucleotide substitutions were associated with HCC, namely sR24K (HBsAg), SI126T (HBsAg), and pcA1846T (precore gene) mutations (P=0.029, 0.001, and 0.008, respectively). HBV harboring deletions in the pre-S region were also associated with increased liver disease severity (chronic hepatitis B vs. cirrhosis, P=0.040; chronic hepatitis B vs. HCC, P=0.040). Despite the high degree of sequence conservation, several key HBV mutations were associated with disease progression. Prospective studies with larger cohorts of patients are required to evaluate further the clinical manifestation of HBV/C2 in Korea.",
author = "SangHoon Ahn and Lilly Yuen and KwangHyub Han and Margaret Littlejohn and Chang, {Hye Young} and Hans Damerow and Anna Ayres and Jeong Heo and Stephen Locarnini and Revill, {Peter A.}",
year = "2010",
month = "1",
day = "1",
doi = "10.1002/jmv.21844",
language = "English",
volume = "82",
pages = "1126--1134",
journal = "Journal of Medical Virology",
issn = "0146-6615",
publisher = "Wiley-Liss Inc.",
number = "7",

}

Ahn, S, Yuen, L, Han, K, Littlejohn, M, Chang, HY, Damerow, H, Ayres, A, Heo, J, Locarnini, S & Revill, PA 2010, 'Molecular and clinical characteristics of hepatitis B virus in Korea', Journal of Medical Virology, vol. 82, no. 7, pp. 1126-1134. https://doi.org/10.1002/jmv.21844

Molecular and clinical characteristics of hepatitis B virus in Korea. / Ahn, SangHoon; Yuen, Lilly; Han, KwangHyub; Littlejohn, Margaret; Chang, Hye Young; Damerow, Hans; Ayres, Anna; Heo, Jeong; Locarnini, Stephen; Revill, Peter A.

In: Journal of Medical Virology, Vol. 82, No. 7, 01.01.2010, p. 1126-1134.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Molecular and clinical characteristics of hepatitis B virus in Korea

AU - Ahn, SangHoon

AU - Yuen, Lilly

AU - Han, KwangHyub

AU - Littlejohn, Margaret

AU - Chang, Hye Young

AU - Damerow, Hans

AU - Ayres, Anna

AU - Heo, Jeong

AU - Locarnini, Stephen

AU - Revill, Peter A.

PY - 2010/1/1

Y1 - 2010/1/1

N2 - Korea is an endemic area of hepatitis B virus (HBV) infection but very little is known about the molecular characteristics of HBV isolates from Korean patients or the association with disease progression. The complete HBV genome sequences from 53 Korean patients with chronic hepatitis B, advanced cirrhosis, or hepatocellular carcinoma (HCC) were analyzed to identify (i) subgenotype distribution and genetic diversity and (ii) signature mutations associated with liver disease progression. With the exception of 1 patient infected with HBV/B, all 52 patients (98.1%) were infected with HBV/C, subgenotype C2. These strains were 98.4% identical and the frequency of amino acid substitutions occurring within key immunological epitopes increased with disease severity. A number of amino acid/ nucleotide substitutions were associated with HCC, namely sR24K (HBsAg), SI126T (HBsAg), and pcA1846T (precore gene) mutations (P=0.029, 0.001, and 0.008, respectively). HBV harboring deletions in the pre-S region were also associated with increased liver disease severity (chronic hepatitis B vs. cirrhosis, P=0.040; chronic hepatitis B vs. HCC, P=0.040). Despite the high degree of sequence conservation, several key HBV mutations were associated with disease progression. Prospective studies with larger cohorts of patients are required to evaluate further the clinical manifestation of HBV/C2 in Korea.

AB - Korea is an endemic area of hepatitis B virus (HBV) infection but very little is known about the molecular characteristics of HBV isolates from Korean patients or the association with disease progression. The complete HBV genome sequences from 53 Korean patients with chronic hepatitis B, advanced cirrhosis, or hepatocellular carcinoma (HCC) were analyzed to identify (i) subgenotype distribution and genetic diversity and (ii) signature mutations associated with liver disease progression. With the exception of 1 patient infected with HBV/B, all 52 patients (98.1%) were infected with HBV/C, subgenotype C2. These strains were 98.4% identical and the frequency of amino acid substitutions occurring within key immunological epitopes increased with disease severity. A number of amino acid/ nucleotide substitutions were associated with HCC, namely sR24K (HBsAg), SI126T (HBsAg), and pcA1846T (precore gene) mutations (P=0.029, 0.001, and 0.008, respectively). HBV harboring deletions in the pre-S region were also associated with increased liver disease severity (chronic hepatitis B vs. cirrhosis, P=0.040; chronic hepatitis B vs. HCC, P=0.040). Despite the high degree of sequence conservation, several key HBV mutations were associated with disease progression. Prospective studies with larger cohorts of patients are required to evaluate further the clinical manifestation of HBV/C2 in Korea.

UR - http://www.scopus.com/inward/record.url?scp=77954397663&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77954397663&partnerID=8YFLogxK

U2 - 10.1002/jmv.21844

DO - 10.1002/jmv.21844

M3 - Article

C2 - 20513074

AN - SCOPUS:77954397663

VL - 82

SP - 1126

EP - 1134

JO - Journal of Medical Virology

JF - Journal of Medical Virology

SN - 0146-6615

IS - 7

ER -